FDA Import Refusal 799-2034921-7/10003/1 — Marks Marine Pharmacy
The FDA refused shipment 799-2034921-7/10003/1 from Marks Marine Pharmacy (Canada) on Feb 20, 2026. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charges: 118,75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Feb 20, 2026
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 118,75